<DOC>
	<DOC>NCT01381432</DOC>
	<brief_summary>This post-marketing surveillance study is to investigate the efficacy and safety of azathioprine tablets in subjects whom lung transplantation is performed.</brief_summary>
	<brief_title>Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Subjects who undergo lung transplantation and azathioprine tablets were administered Subjects with hypersensitivity to the ingredients of azathioprine tablet Subjects who is pregnant or might be pregnant Subjects whose white count is lower than 3000/cubic millimeter</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Antirejection</keyword>
</DOC>